Topiramate Tablet, Film Coated
Product Images NDC 0904-6928

5 FDA label images from Major Pharmaceuticals · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Topiramate (NDC 0904-6928). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Major Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structured Product Formula For Topiramate (7ea951b6 B020 481f 8acc 12fb7a3a69fd 01)

Structured Product Formula For Topiramate (7ea951b6 B020 481f 8acc 12fb7a3a69fd 01)
Chemical structure of the active ingredient topiramate, displaying its molecular arrangement including carbon, oxygen, sulfur, nitrogen, and hydrogen atoms represented by structural bonds and rings.*
FDA Label Image

Structured Product Formula For Topiramate (7ea951b6 B020 481f 8acc 12fb7a3a69fd 02)

Structured Product Formula For Topiramate (7ea951b6 B020 481f 8acc 12fb7a3a69fd 02)
A Kaplan-Meier curve showing cumulative rates for time to first seizure in patients taking topiramate at 50 mg/day and 400 mg/day doses. The x-axis represents time in days up to 500 days, and the y-axis shows cumulative seizure rates from 0.00 to 0.50. The solid line is for 50 mg/day (N=234), and the dashed line is for 400 mg/day (N=236), indicating lower cumulative seizure rates at the higher dose over time.*
FDA Label Image

Topiramate Tablets Usp (7ea951b6 B020 481f 8acc 12fb7a3a69fd 03)

Topiramate Tablets Usp (7ea951b6 B020 481f 8acc 12fb7a3a69fd 03)
A bar chart showing the change from baseline to double-blind phase in average monthly migraine period rate (+SE) for placebo and topiramate at doses 50 mg/day, 100 mg/day, and 200 mg/day from two studies (Study 11 and Study 12). Bars illustrate the reduction in migraine rates, with greater decreases seen at 100 mg/day and 200 mg/day doses, and statistical significance indicated for these doses.*
FDA Label Image

Carton Label (Image 01)

Carton Label (Image 01)
Label for Topiramate 25 mg oral film-coated tablets by Major Pharmaceuticals. It includes the NDC 0904-6928-61, specifying unit dose packaging of 100 tablets. The label notes Rx-only status and provides usage instructions, storage conditions, and distributor information for Major Pharmaceuticals in Livonia, MI.*
FDA Label Image

Carton Label (Image 02)

Carton Label (Image 02)
Label for Topiramate Tablets USP 100 mg, film-coated oral tablets. The label indicates unit dose packaging containing 100 tablets. Distributed by Major Pharmaceuticals, with storage instructions and cautionary information for pharmacists and users. The label features the NDC code 0904-6929-61.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.